Summary
On 25 June 2024, China's State Administration for Market Regulation and New Zealand's Ministry for Primary Industries signed the Arrangement on Food Safety Cooperation for Infant Formula, aiming to enhance communication and cooperation in the registration of infant formula, ensure the quality and safety of infant formula exported to China, and facilitate bilateral trade. The cooperation will involve technical discussions and exchanges through existing forums, exploring further collaboration in areas of common interest. Bai Wenxi, Vice Chairman of the China Enterprise Capital Union, believes the cooperation will strengthen exchanges between the two countries in infant formula production, regulation, and testing, creating a fairer and more transparent market environment.
Song Liang, an independent dairy analyst, noted that the cooperation will promote innovation in infant formula raw materials and nutrition, as well as the development of food safety testing technologies. China's annual random inspection pass rate for infant formula exceeds 99%, reflecting strict regulation. New Zealand is China's largest source of imported dairy products, with dairy exports of NZ$26.008 billion in 2023, of which China accounted for 35%.
From January to November 2023, New Zealand dominated categories such as whole milk powder, cheese, and cream, but in infant formula, the US and EU held the lead. Song Liang indicated that changes in China's demand structure, with increased demand for butter, cheese, concentrated milk, and whey powder, are prompting New Zealand to adjust its export structure. The cooperation will help New Zealand increase its market share of infant formula in China and strengthen comprehensive collaboration.
Commentary
For New Zealand small and medium-sized enterprise owners, particularly those in the dairy sector, this China-New Zealand infant formula safety cooperation arrangement sends a clear signal: China's demand for high-value-added dairy products is growing, and New Zealand, as a traditional raw material supplier, faces a window of opportunity for product structure upgrade. Data shows that in 2023, New Zealand's dairy exports reached NZ$26 billion, with China accounting for 35%, but imports of whole milk powder fell by 26.5%, while cheese imports grew by 27.7%, indicating a shift in Chinese demand from bulk commodities to high-value-added products. This cooperation focusing on infant formula is a strategic move by New Zealand to adapt to this change.
From a positive perspective, the cooperation will simplify registration procedures, improve customs clearance efficiency, and reduce compliance costs. For infant formula companies already established in the Chinese market, this means more stable market expectations and faster product launch cycles. Additionally, technical exchanges may lead to mutual recognition of testing standards, reducing duplicate testing costs.
For companies planning to enter the Chinese market, the cooperation lowers entry barriers, especially for small and medium brands that can compete under more transparent rules. However, from a risk perspective, the cooperation may also intensify competition. China's infant formula market is already highly concentrated, with leading brands such as Feihe and Yili dominating, and imported brands facing localisation challenges.
New Zealand companies need to invest more resources in brand building, channel expansion, and consumer trust, rather than relying solely on origin advantages. Moreover, China's regulation of infant formula continues to tighten; the revised registration management measures in 2023 raised the bar for formula registration. While the cooperation facilitates processes, compliance requirements will not be relaxed.
For non-dairy SMEs, this cooperation indirectly signals the deepening trend of China-New Zealand economic and trade relations. The New Zealand government is actively promoting high-value-added exports to China, which may extend to other food sectors such as honey and meat. SMEs should pay attention to niche market opportunities arising from China's consumption upgrade, such as organic and functional foods.
Meanwhile, technical exchanges under the cooperation framework may foster new collaboration models, such as joint research and development or standard mutual recognition, which are worth cross-industry reference. Overall, this cooperation arrangement epitomises the deepening of China-New Zealand economic and trade ties, bringing both market access facilitation and the need for companies to enhance product differentiation. SMEs should assess their supply chains and brand strategies to seize the window of opportunity for high-value-added transformation.
Keywords: infant formula, food safety, China-New Zealand cooperation, registration, trade facilitation, high value-added, market access, dairy products, regulation, New Zealand
Summary in Chinese | 摘要
2024年6月25日，中国国家市场监督管理总局与新西兰初级产业部签署了《关于婴幼儿配方乳粉食品安全合作安排》，旨在加强双方在婴配乳粉注册领域的沟通与合作，保障输华婴配乳粉质量安全，便利双边贸易。该合作通过现有论坛开展技术讨论和交流，探索共同关心领域的进一步合作。中国企业资本联盟副理事长柏文喜认为，合作将加强两国在婴配乳粉生产、监管、检测等方面的交流，创造更公平透明的市场环境。
独立乳业分析师宋亮指出，合作将促进婴配乳粉原料和营养领域的创新，以及食品安全检测技术的研发。中国婴配乳粉年度抽检合格率超99%，监管严格。新西兰作为中国进口乳制品第一大来源国，2023年乳制品出口额260.08亿新元，中国占35%。
2023年1-11月，新西兰在大包粉、奶酪、奶油等品类占主导，但婴配粉领域美国、欧盟占优。宋亮表示，中国需求结构变化，增加对黄油、奶酪、浓缩乳、乳清粉等需求，新西兰正调整出口结构。合作有助于新西兰提升婴配乳粉在中国市场份额，并加强全面合作。
Commentary in Chinese | 评论
对于新西兰中小企业主，尤其是乳制品相关企业，这份中新婴配乳粉安全合作安排释放了明确信号：中国市场对高附加值乳制品的需求正在增长，而新西兰作为传统原料供应国，正面临产品结构升级的窗口期。从数据看，2023年新西兰乳制品出口额260亿新元，中国占35%，但大包粉进口量下降26.5%，而奶酪进口量增长27.7%，表明中国市场需求从大宗原料转向高附加值产品。此次合作聚焦婴配乳粉，正是新西兰适应这一变化的战略举措。
从正面视角看，合作将简化注册流程、提升通关效率，降低合规成本。对于已在中国市场布局的婴配粉企业，这意味着更稳定的市场预期和更快的产品上市周期。同时，技术交流可能带来检测标准互认，减少重复检测费用。
对于计划进入中国市场的企业，合作降低了准入门槛，尤其是中小品牌有机会借助更透明的规则参与竞争。然而，从风险视角看，合作也可能加剧竞争。中国婴配粉市场已高度集中，头部品牌如飞鹤、伊利占据主导，进口品牌面临本土化挑战。
新西兰企业需在品牌建设、渠道下沉和消费者信任方面投入更多资源，而非仅依赖产地优势。此外，中国对婴配粉的监管持续收紧，2023年修订的注册管理办法提高了配方注册门槛，合作虽便利化，但合规要求不会降低。对非乳制品行业的中小企业，这一合作间接提示了中新经贸关系的深化趋势。
新西兰政府正积极推动高附加值产品对华出口，未来可能延伸至其他食品领域，如蜂蜜、肉类等。中小企业应关注中国消费升级带来的细分市场机会，例如有机、功能性食品。同时，合作框架下的技术交流可能催生新的合作模式，如联合研发或标准互认，值得跨行业借鉴。
总体而言，这份合作安排是中新经贸关系深化的缩影，既带来市场准入便利，也要求企业提升产品差异化能力。中小企业需评估自身供应链和品牌策略，抓住高附加值转型的窗口期。
关键词: 婴幼儿配方乳粉, 食品安全, 中新合作, 注册, 贸易便利化, 高附加值, 市场准入, 乳制品, 监管, 新西兰
Source: NetEase
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.
免责声明：本文基于公开信息编译，仅供一般性参考。文中分析与评论为编辑观点。MiDeer Observer 不对所提供信息的准确性或完整性作出保证。读者在依赖本文内容前，应寻求独立专业意见，或联系我们获取更多信息。